首页> 外国专利> NOVEL SYNTHETIC PEPTIDE, LUBGS SURFACTANT CONTAINING SUCH PEPTIDE AND AGENT FOR TREATING RESPIRATORY INSUFFICIENCY SYNDROME

NOVEL SYNTHETIC PEPTIDE, LUBGS SURFACTANT CONTAINING SUCH PEPTIDE AND AGENT FOR TREATING RESPIRATORY INSUFFICIENCY SYNDROME

机译:新型合成肽,含此类肽的表面活性剂和用于治疗呼吸衰竭综合症的药物

摘要

A synthetic peptide containing the following sequence: Xaa-Pro-Val-Xbb-Xcc-Lys-Arg-W, (wherein Xaa is absent or represents Cys or Ser; Xbb represents His or Asn; Xcc represents Leu or Ile; and W represents a hydrophobic peptide portion); an intermediate for producing the peptide; a process for producing the peptide; a lung surfactant comprising the peptide and a lipid mixture; and a remedy for respiratory distress syndrome containing the surfactant as the active ingredient. The peptide is easy to isolate and purify and suitable for mass production. As it is highly soluble in methanol and the like, it can readily be blended with a lipid mixture and is suited for the preparation of a lung surfactant. As the lung surfactant has a good suspensibility and a potent surface activity, it is useful as a remedy for respiratory distress syndrome.
机译:包含以下序列的合成肽:Xaa-Pro-Val-Xbb-Xcc-Lys-Arg-W,(其中Xaa不存在或代表Cys或Ser; Xbb代表His或Asn; Xcc代表Leu或Ile; W代表疏水肽部分);用于产生肽的中间体;产生肽的方法;包含所述肽和脂质混合物的肺表面活性剂;含有表面活性剂作为有效成分的呼吸窘迫综合症的药物。该肽易于分离和纯化,适合大规模生产。由于它高度溶于甲醇等,因此可以很容易地与脂质混合物混合,适合于制备肺表面活性剂。由于肺表面活性剂具有良好的悬浮性和有效的表面活性,因此可用作呼吸窘迫综合征的治疗药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号